Log in to save to my catalogue

The Rationale for Potential Pharmacotherapy of COVID-19

The Rationale for Potential Pharmacotherapy of COVID-19

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_78c677328cd6461fb629b1d535889f86

The Rationale for Potential Pharmacotherapy of COVID-19

About this item

Full title

The Rationale for Potential Pharmacotherapy of COVID-19

Publisher

Switzerland: MDPI

Journal title

Pharmaceuticals (Basel, Switzerland), 2020-05, Vol.13 (5), p.96

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI

More information

Scope and Contents

Contents

On 11 March 2020, the coronavirus disease (COVID-19) was defined by the World Health Organization as a pandemic. Severe acute respiratory syndrome-2 (SARS-CoV-2) is the newly evolving human coronavirus infection that causes COVID-19, and it first appeared in Wuhan, China in December 2019 and spread rapidly all over the world. COVID-19 is being incr...

Alternative Titles

Full title

The Rationale for Potential Pharmacotherapy of COVID-19

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_78c677328cd6461fb629b1d535889f86

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_78c677328cd6461fb629b1d535889f86

Other Identifiers

ISSN

1424-8247

E-ISSN

1424-8247

DOI

10.3390/ph13050096

How to access this item